Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles

Miklos Diossy, Viktoria Tisza, Hua Li, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nousome, Claire Kuo, Yongmei Chen, Reinhard Ebner, Isabell A. Sesterhenn, Joel T. Moncur, Gregory T. Chesnut, Gyorgy Petrovics, Gregory T. Klus, Sandor Spisak, Gabor Valcz, Pier Vitale Nuzzo, Dezso Ribli, Aimilia Schina, Judit Börcsök, Aurel Prosz, Marcin Krzystanek, Thomas Ried, David Szuts, Salma Kaochar, Shailja Pathania, Alan D. D’Andrea, Istvan Csabai, Shiv Srivastava, Albert Dobi, Matthew L Freedman, Zoltan Szallasi
doi: https://doi.org/10.1101/2021.02.08.21251199
Miklos Diossy
1Danish Cancer Society Research Center, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viktoria Tisza
2Computational Health Informatics Program, Boston Children’s Hospital, USA, Harvard Medical School, Boston, USA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Li
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jia Zhou
6Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsofia Sztupinszki
1Danish Cancer Society Research Center, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise Young
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryl Nousome
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Kuo
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongmei Chen
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinhard Ebner
7CytoTest Inc., Rockville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabell A. Sesterhenn
8Joint Pathology Center, Silver Spring, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel T. Moncur
8Joint Pathology Center, Silver Spring, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory T. Chesnut
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gyorgy Petrovics
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
5The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory T. Klus
2Computational Health Informatics Program, Boston Children’s Hospital, USA, Harvard Medical School, Boston, USA
9Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandor Spisak
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
10Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabor Valcz
11MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences, 1051 Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pier Vitale Nuzzo
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
10Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dezso Ribli
12Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimilia Schina
1Danish Cancer Society Research Center, Copenhagen, Denmark
13National Center for Cancer Immune Therapy, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judit Börcsök
1Danish Cancer Society Research Center, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurel Prosz
1Danish Cancer Society Research Center, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcin Krzystanek
1Danish Cancer Society Research Center, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Ried
9Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Szuts
14Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salma Kaochar
15Department of Medicine, Baylor College of Medicine, Houston, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shailja Pathania
16Center for Personalized Cancer Therapy, University of Massachusetts, Boston, MA
17Department of Biology, University of Massachusetts, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan D. D’Andrea
6Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
18Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Istvan Csabai
12Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiv Srivastava
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
19Department of Biochemistry and Molecular & Cell Biology, Georgetown University School of Medicine, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Dobi
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
4Center for Prostate Disease Research, Murtha Cancer Center / Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew L Freedman
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
10Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
20The Eli and Edythe L. Broad Institute, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoltan Szallasi
1Danish Cancer Society Research Center, Copenhagen, Denmark
2Computational Health Informatics Program, Boston Children’s Hospital, USA, Harvard Medical School, Boston, USA
212nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background African American (AA) men have significantly higher mortality rates from prostate cancer (PC) than individuals of European ancestry (EA). Therapeutically targetable molecular differences may hold the potential to reduce this disparity.

Objective To investigate chromodomain helicase DNA-binding protein 1 (CHD1) deletion both as a cause of aggressive disease and therapeutic vulnerability in the prostate cancer of AA men.

Design, setting, and participants 91 AA and 109 EA prostate cancer cases were analyzed by fluorescence in situ hybridization (FISH) for the deletion of CHD1. Whole exome and whole genome sequencing data from prostate adenocarcinoma cases were analyzed for mutational signatures from AA and EA individuals.

Outcome measurements and statistical analysis Associations with biochemical recurrence were evaluated using Cox proportional hazard regression models. Association between mutational signatures and CHD1 deletion were assessed by Wilcoxon ranked sum tests.

Results and limitations Subclonal deletion of CHD1 is nearly three times as frequent in prostate tumors of men than in EA men. CHD1 deletion is associated with some of the homologous recombination deficiency associated mutational signatures in prostate cancer. In a cell line model CHD1 deletion induced 1-10 kb deletions resembling those induced by BRCA2 deficiency. CHD1 deficient cells showed markedly increased sensitivity to both talazoparib and the radiomimetic bleomycin.

Conclusions CHD1 is more frequently deleted in the prostate cancer of AA men. This deletion is both associated with and induces mutational signatures characteristic of BRCA2 deficiency. CHD1 deficient prostate cancer is more sensitive to talazoparib or bleomycin treatment.

Patient summary Subclonal deletion of CHD1 is more frequent in the prostate cancer of AA men and this could be one of the reasons behind more aggressive disease. CHD1 deletion, however, also constitutes a therapeutic vulnerability to the PARP inhibitor talazoparib. This treatment may significantly improve the outcome of disease in AA men.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Research and Technology Innovation Fund (KTIA_NAP_13-2014-0021 and NAP2-2017-1.2.1-NKP-0002); Breast Cancer Research Foundation (BCRF-17-156 to Z. Szallasi) and the Novo Nordisk Foundation Interdisciplinary Synergy Program Grant (NNF15OC0016584), Det Fri Forskningsrad (award number #7016-00345B; to Z. Szallasi); Department of Defense through the Prostate Cancer Research Program (award number is W81XWH-18-2-0056; to Z. Szallasi, A. Dobi and M.L. Freedman). Z. Szallasi, Z. Sztupinszki and J. Borcsok were supported by Velux Foundation 00018310 grant. S.K. is supported by the Prostate Cancer Foundation (18YOUN09 and 19CHAL07).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Our study was reviewed and approved by institutional review board (IRB) of Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences, Bethesda, MD.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The Mayo Clinic whole genomes (Decker et al. 2016) are available at dbGaP under accession number phs001105.v1.p1, the DFCI whole genomes are deposited under accession number phs000661.v1.p. The TCGA whole genomes and whole exomes are available through the ICGC and GDC data portals respectively.

https://portal.gdc.cancer.gov/

https://dcc.icgc.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 11, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles
Miklos Diossy, Viktoria Tisza, Hua Li, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nousome, Claire Kuo, Yongmei Chen, Reinhard Ebner, Isabell A. Sesterhenn, Joel T. Moncur, Gregory T. Chesnut, Gyorgy Petrovics, Gregory T. Klus, Sandor Spisak, Gabor Valcz, Pier Vitale Nuzzo, Dezso Ribli, Aimilia Schina, Judit Börcsök, Aurel Prosz, Marcin Krzystanek, Thomas Ried, David Szuts, Salma Kaochar, Shailja Pathania, Alan D. D’Andrea, Istvan Csabai, Shiv Srivastava, Albert Dobi, Matthew L Freedman, Zoltan Szallasi
medRxiv 2021.02.08.21251199; doi: https://doi.org/10.1101/2021.02.08.21251199
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles
Miklos Diossy, Viktoria Tisza, Hua Li, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nousome, Claire Kuo, Yongmei Chen, Reinhard Ebner, Isabell A. Sesterhenn, Joel T. Moncur, Gregory T. Chesnut, Gyorgy Petrovics, Gregory T. Klus, Sandor Spisak, Gabor Valcz, Pier Vitale Nuzzo, Dezso Ribli, Aimilia Schina, Judit Börcsök, Aurel Prosz, Marcin Krzystanek, Thomas Ried, David Szuts, Salma Kaochar, Shailja Pathania, Alan D. D’Andrea, Istvan Csabai, Shiv Srivastava, Albert Dobi, Matthew L Freedman, Zoltan Szallasi
medRxiv 2021.02.08.21251199; doi: https://doi.org/10.1101/2021.02.08.21251199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5872)
  • Intensive Care and Critical Care Medicine (362)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (233)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2012)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)